ReviewMolecular therapy. Nucleic acids2025

Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges.

Nechama Kalter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.